SECOND SUPPLEMENTAL INDENTURESecond Supplemental Indenture • January 11th, 2013 • Elan Corp PLC • Pharmaceutical preparations
This Second Supplemental Indenture, dated as of January 11, 2013 (this “Supplemental Indenture”), among Elan Finance public limited company, a public limited company incorporated and registered under the laws of Ireland (together with its successors and assigns), Elan Finance Corp., a Delaware corporation (together with its successors and assigns, collectively the “Issuers”), Elan Corporation, plc (the “Company”), Elan Pharmaceuticals GmbH, a Swiss limited liability company (the “New Note Guarantor”) and each other Note Guarantor under the Indenture referred to below, and The Bank of New York Mellon, London Branch, as successor trustee (the “Trustee”) under the Indenture referred to below.
